格莱卡普雷维尔/皮布伦塔斯维尔治疗创伤后压力障碍
Bradley V Watts1, Jessica E Hoyt2, Krista D Disano3
1Watts, MD, MPH, Larner College of Medicine at the University of Vermont, Burlington VT; White River Junction VA Medical Center, White River Junction VT; VA Office of Rural Health, White River Junction VT.
Psychopharmacology bulletin
|January 14, 2026
概括
格莱卡普雷维尔/皮布伦塔斯维尔 (GLE/PIB) 在减少创伤后应激障碍 (PTSD) 症状方面表现有前途,并可能调节炎症. 需要进一步的研究来证实这些发现用于PTSD治疗.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 创伤后应激障碍 (PTSD) 是一种普遍存在的心理健康状况,药物治疗效果有限.
- 针对C型肝炎病毒 (HCV) 的抗病毒药物格莱卡普雷维尔/皮布伦塔斯维尔 (GLE/PIB) 在初步研究中显示为PTSD治疗的潜力.
- 炎症在PTSD病原体中的作用表明潜在的治疗点.
研究的目的:
- 调查GLE/PIB在减少PTSD症状中的有效性.
- 探索GLE/PIB治疗对患有PTSD的退伍军人炎症生物标志物的影响.
- 评估GLE/PIB在PTSD治疗中的安全性和耐受性.
主要方法:
- 进行了一项开放式,不受控制的试验,其中包括十名美国退伍军人,他们被诊断患有PTSD而没有感染HCV.
- 参与者每天接受GLE/PIB (100 mg/40 mg) 治疗,持续时间为8周.
- 使用临床医生管理的DSM 5 (CAPS-5) PTSD尺度评估PTSD症状,并在3个月和6个月后进行随访. 血清炎症生物标志物在基线和治疗后被分析.
主要成果:
- GLE/PIB治疗导致PTSD症状显著减少,在6个月的随访中观察到很大的效果大小 (CAPS-5:d = 1.6,p < 0.01).
- 8名参与者实现了治疗反应,其中6人满足了全面PTSD缓解的标准 (CAPS-5分数<12).
- 较低的基线互白素-27 (IL-27) 水平预测了治疗反应,治疗期间IL-9水平的变化与症状改善相关.
结论:
- GLE/PIB显示出作为PTSD有效治疗的潜力,在一小部分患者中显著改善症状并实现缓解.
- 治疗可以调节与PTSD相关的炎症反应,如IL-27和IL-9水平的变化所示.
- 需要进一步严格的临床试验来证实GLE/PIB在PTSD管理中的有效性和机制及其对炎症的影响.
相关概念视频
Post-traumatic Stress Disorder
475
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
475
Treatment Strategies for Psychological Disorders
721
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
721
Electroconvulsive Therapy
864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
Social Anxiety Disorder
436
Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.
436
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457
Panic Disorder
621
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
621


